Sanofi debuts prostate cancer drug Jevtana in UK - Pharmaceutical and Biotechnology News - Pharma Letter
Links shared publicly online about this topic.
- 169total visits
Sanofi debuts prostate cancer drug Jevtana in UK - Pharmaceutical and Biotechnology News - Pharma Letter
French drug major Sanofi (Euronext: SAN) yesterday announced the UK launch of Jevtana (cabazitaxel), in combination with prednisone/prednisolone for the treatment of men with mHRPC previously treated with docetaxel.
View full resource at thepharmaletter.com
Tags: Cancer, Cancer Medication, Prostate Cancer, Prostate Cancer Medication, Prostate, Drug, Men's Health, Sanofi-Aventis
Most Recently Shared on July 5, 2011 at 10:43 am By:
Sanofi debuts prostate cancer drug Jevtana in UK http://bit.ly/lHx4YB
Advertisement
